AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaford M 100mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Leeford Healthcare Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitaford M 100mg/500mg Tablet SR

Diabexe Duo 100mg/500mg Extended-Release Tablets combine two medications to manage elevated blood glucose in adults with type 2 diabetes. This dual action helps prevent severe diabetic complications like kidney disease and vision loss, potentially lowering the risk of heart attack or stroke. Diabexe Duo may be used alone or with other diabetes treatments, and its effectiveness is maximized with a healthy diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and other medications. Consuming it with meals minimizes stomach upset. Consistent daily dosing at the same time is crucial for optimal results; discontinue only under your doctor's guidance. Adherence to your prescribed diet and exercise plan is essential. Lifestyle choices significantly impact diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and throat irritation. Low blood sugar (hypoglycemia) is possible, especially when combined with insulin or sulfonylureas; learn its signs and management. This medication isn't suitable for all patients. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should consult their physician. Interactions with other drugs are possible, so disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor your kidney function and blood sugar levels throughout treatment.

Uses of Sitaford M 100mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sitaford M 100mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Sitaford M 100mg/500mg Sustained-Release Tablets should be administered with a meal.

Common Side effects of Sitaford M 100mg/500mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaford M 100mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitaford M 100mg/500mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with a meal.

How Sitaford M 100mg/500mg Tablet SR works:

Sitaford M 100mg/500mg Extended-Release Tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, enhances insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Sitaford M 100mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaford M 100mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sitaford M 100mg/500mg tablet is likely unsafe for breastfeeding mothers. Available data from human studies indicates potential transfer to breast milk with the possibility of infant harm.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaford M 100mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Sitaford M 100mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The use of Sitaford M 100mg/500mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitaford M 100mg/500mg Tablet SR :

Should you forget a dose of Sitaford M 100mg/500mg sustained-release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaford M 100mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes medication

FAQs on Sitaford M 100mg/500mg Tablet SR

Sitaford M 100mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitaford M 100mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Sitaford M 100mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaford M 100mg/500mg Tablet SR is contraindicated in patients allergic to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaford M 100mg/500mg Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitaford M 100mg/500mg SR) can cause lactic acidosis, a serious condition with high blood lactic acid levels (also known as MALA). While rare, this risk is higher in patients with kidney problems, the elderly, or those who consume excessive alcohol. Symptoms include muscle aches, weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaford M 100mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaford M 100mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaford M 100mg/500mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaford M 100mg/500mg Tablet SR with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitaford M 100mg/500mg SR) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This risk is increased in patients with kidney disease, older adults, and heavy alcohol users, hence metformin is avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaford M 100mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaford M 100mg/500mg SR tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaford M 100mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaford M 100mg/500mg Tablet SR is contraindicated in patients allergic to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaford M 100mg/500mg Tablet SR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitaford M 100mg/500mg SR) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called MALA – Metformin-associated lactic acidosis). This rare side effect is reason to avoid this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitaford M 100mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually, according to some research.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaford M 100mg/500mg Ta...
261
MRP 303
13% off